In vitro effects of 2-methoxyestradiol-bis-sulphamate on cell growth, morphology and cell cycle dynamics in the MCF-7 breast adenocarcinoma cell line

Biocell

Volumn 34, Issue 2, 2010, Pages 71-79

  Vorster, Chris ^a   Joubert, Annie ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

2 methoxyestradiol; Apoptosis; Autophagy; Cancer; Estradiol derivative; Sulphamoylated

Indexed keywords

2 METHOXYESTRADIOL; 2 METHOXYESTRADIOL DISULFAMATE; CYCLIN B1; UNCLASSIFIED DRUG; 2 METHOXYESTRIOL; 2-METHOXYESTRIOL; DRUG DERIVATIVE; ESTRIOL;

APOPTOSIS; ARTICLE; AUTOPHAGY; BREAST ADENOCARCINOMA; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE REGULATION; CELL DEATH; CELL DENSITY; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL STRUCTURE; CELL ULTRASTRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG STRUCTURE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IN VITRO STUDY; INHIBITION KINETICS; MICROSCOPY; MITOSIS; BREAST TUMOR; CELL SHAPE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; FEMALE; TUMOR CELL LINE; ULTRASTRUCTURE;

BREAST NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SHAPE; ESTRIOL; FEMALE; HUMANS; MOLECULAR STRUCTURE;

EID: 78349241729     PISSN: 03279545     EISSN: 16675746     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Attalla H, Makela T, Adlercreutz H, Andersson L (1996). 2-Methoxyestradiol arrests cells in mitosis without depolymerizing tubulin. Biochemical and Biophysical Research Communications 228: 467-473.
2. Bàrdos J, Ashcroft M (2005). Negative and positive regulation of HIF-1: A complex network. Biochimica et Biophysica Acta 1755: 107-120.
3. Chander S, Foster P, Leese M, Newman S, Potter B, Purohit A (2007). In vivo inhibition of angiogenesis by sulphamoylated derivatives of 2-methoxyoestradiol. British Journal of Cancer 96: 1368 -1376.
4. Foster P, Ho Y, Newman S, Kasprzyk P, Leese M, Potter B (2008). 2-MeOE2bisMATE and 2-EtE2bisMATE induce cell cycle arrest and apoptosis in breast cancer xenografts as shown by a novel ex vivo technique. Breast Cancer Research and Treatment 111: 251-260.
5. Hait W, Rubin E, Alli E, Goodin S (2007). Tubulin Targeting Agents. Update on Cancer Therapeutics 2: 1-18.
6. Hayat M (1981). Biological Applications - Principles and techniques of electron microscopy (Vol. 1). University Park Press, Baltimore.
7. Ho Y, Newman S, Purohit A, Leese M, Potter B, Reed M (2003). The effects of 2-methoxy oestrogens and their sulphamoylated derivatives in conjunction with TNF-alpha on endothelial and fibroblast cell growth, morphology and apoptosis. Journal of Steroid Biochemistry and Molecular Biology 86: 189-196.
8. Ireson C, Chander S, Purohit A, Perera S, Newman S, Parish D (2004). Pharmacokinetics and efficacy of 2-Methoxyoestradiol and 2-methoxyoestradiol-bis-sulphamate in vivo in rodents. British Journal of Cancer 90: 932-937.
9. James J, Murry D, Treston A, Storniolo A, Sledge G, Sidor C (2006). Phase I safety, pharmacokinetic and pharmacodynamic studies of 2-methoxyestradiol alone or in combination with docetaxel in patients with locally recurrent or metastatic breast cancer. Investigational New Drugs 25: 41-48.
10. Klauber N, Parangi S, Flynn E, Hamel E, D'Amato R (1997). Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol. Cancer Research 57: 81-86.
11. Lakhani N, Sarkar M, Venitz J, Figg W (2003). 2-Methoxyestradiol, a promising anticancer agent. Pharmacotherapy 23: 165-172.
12. Mooberry S (2003a). Mechanism of action of 2-methoxyestradiol: new developments. Drug Resistance Updates 6: 355-361.
13. Mooberry S (2003b). New insights into 2-methoxyestradiol, a promising antiangiogenic and antitumor agent. Current Opinion in Oncology 15: 425-430.
14. Nakagawa-Yagi Y, Ogane N, Inoki Y, Kitoh N (1996). The endogenous estrogen metabolite 2-methoxyestradiol induces apoptotic neuronal cell death in vitro. Life Sciences 58: 1461-1467.
15. Purohit A, Vernon K, Wagenaar Hummelinck A, Woo L, Hejaz H, Potter B (1998). The development of A-ring modified analogues of oestrone-3-O-sulphamate as potent steroid sulphatase inhibitors with reduced oestrogenicity. Journal of Steroid Biochemistry and Molecular Biology 64: 269-275.
16. Purohit A, Woo L, Chander S, Newman S, Ireson C, Ho Y (2003). Steroid sulphatase inhibitors for breast cancer therapy. Journal of Steroid Biochemistry and Molecular Biology 86: 423-432.
17. Raobaikady B, Purohit A, Chander S, Woo L, Leese M, Potter B (2003). Inhibition of MCF-7 breast cancer cell proliferation and in vivo steroid sulphatase activity by 2-methoxyoestradiolbis-sulphamate. Journal of Steroid Biochemistry and Molecular Biology 84: 351-358.
18. Strimpakos A, Karapanagiotou E, Saif M, Syrigos K (2009). The role of mTOR in the management of solid tumors: An overview. Cancer Treatment Reviews 35: 148-159.
19. Sutherland T, Anderson R, Hughes R, Altmann E, Schuliga M, Ziogas J (2007). 2-Methoxyestradiol-a unique blend of activities generating a new class of anti-tumour/anti-inflammatory agents. Drug Discovery Today 12: 577-584.
20. Suzuki R, Newman S, Purohit A, Leese M, Potter B, Reed M (2003). Growth inhibition of multi-drug-resistant breast cancer cells by 2-methoxyoestradiol-bis-sulphamate and 2-ethyloestradiolbis-sulphamate. Journal of Steroid Biochemistry & Molecular Biology 84: 269-278.
21. Utsumi T, Leese M, Chander S, Gaukroger K, Purohit A, Newman S (2005). The effects of 2-methoxyoestrogen sulphamates on the in vitro and in vivo proliferation of breast cancer cells. Journal of Steroid Biochemistry & Molecular Biology 94: 219-227.
22. Wang H, Myc A, Koenig R, Bretz J, Arscott P, Baker J (2000). 2-Methoxyestradiol, an endogenous estrogen metabolite, induces thyroid cell apoptosis. Molecular and Cellular Endocrinology 165: 163-172.